The European Committee for Treatment & Research in Multiple Sclerosis - the world's largest organisation dedicated to treatment & research in MS | #ECTRIMS

Basel, Schweiz
Joined July 2012
๐ŸŒ Donโ€™t forget to join us at Patient Community Day on 23 Oct at 15:00 EDT. Engage with global experts, share your questions, and be part of the conversation driving MS research forward. ๐’๐ข๐ ๐ง ๐ฎ๐ฉ โžก๏ธ bit.ly/44elQGb #ECTRIMS4me #PatientCommunityDay #MS #NMOSD #MOGAD
5
1
8
1,351
๐Ÿ” How can a simple blood test help monitor MS? Our latest Spotlight, ๐˜œ๐˜ด๐˜ช๐˜ฏ๐˜จ ๐˜•๐˜ง๐˜“ ๐˜ช๐˜ฏ ๐˜Š๐˜ญ๐˜ช๐˜ฏ๐˜ช๐˜ค๐˜ข๐˜ญ ๐˜Š๐˜ข๐˜ณ๐˜ฆ, explores how neurofilament light chain (NfL), a marker of neuroaxonal injury that can be measured in the blood, is increasingly used in routine multiple sclerosis care to monitor disease activity, progression and treatment response, alongside MRI. ๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐’๐ฉ๐จ๐ญ๐ฅ๐ข๐ ๐ก๐ญ ๐ก๐ž๐ซ๐ž: ectrims.eu/using-nfl-in-clinโ€ฆ โ€œNfL is almost the perfect biomarkerโ€ฆ We can measure it repeatedly in the blood, keep the samples at room temperature for several days, freeze and thaw them at least three times without affecting the levels,โ€ says Professor Jan Lycke of the University of Gothenburg. โ€œBy tracking repeated measurements in individual patients, clinicians can follow the development of the disease,โ€ adds Professor Tomas Olsson of the Karolinska Institutet. The @ECTRIMS Spotlight Series is curated and authored by our Scientific Content Writer, Stefania de Vito, PhD. @goteborgsuni, @karolinskainst #MultipleSclerosis #MSResearch #Biomarkers #NfL #Neurology #MSSpotlight #ECTRIMS
1
7
380
๐ŸŽ™๏ธ Day Three at MSToronto2026 โ€“ and itโ€™s time to bring an extraordinary week of MS science together. For the final episode in our special MSToronto2026 podcast series, Jaume Sastre-Garriga, @ECTRIMS Executive Committee member, joins host Brett Drummond direct from Toronto. First, they unpack some of the key insights and conversations from Day Three. Then they step back and look at the bigger picture. ๐Ÿ”ฌ What stood out across the Joint Meeting, including at the Late Breaking Abstract session? ๐Ÿ’ก Which ideas and developments could have lasting significance? ๐ŸŒŽ And as the MS community prepares to leave Toronto, ๐ฐ๐ก๐š๐ญ ๐๐จ ๐ฐ๐ž ๐ญ๐š๐ค๐ž ๐ฐ๐ข๐ญ๐ก ๐ฎ๐ฌ โ€“ ๐š๐ง๐ ๐ฐ๐ก๐ž๐ซ๐ž ๐๐จ ๐ฐ๐ž ๐ ๐จ ๐ง๐ž๐ฑ๐ญ? After a week of new research, debate, collaboration and conversation, this final episode is a chance to reflect on ๐ฐ๐ก๐š๐ญ ๐Œ๐’๐“๐จ๐ซ๐จ๐ง๐ญ๐จ2026 ๐ก๐š๐ฌ ๐ญ๐จ๐ฅ๐ ๐ฎ๐ฌ ๐š๐›๐จ๐ฎ๐ญ ๐ฐ๐ก๐ž๐ซ๐ž ๐ญ๐ก๐ž ๐Œ๐’ ๐Ÿ๐ข๐ž๐ฅ๐ ๐ข๐ฌ ๐ญ๐จ๐๐š๐ฒ โ€“ ๐š๐ง๐ ๐ฐ๐ก๐ž๐ซ๐ž ๐ข๐ญ ๐ฆ๐š๐ฒ ๐›๐ž ๐ก๐ž๐š๐๐ข๐ง๐  ๐ง๐ž๐ฑ๐ญ. ๐ŸŽง ๐‹๐ข๐ฌ๐ญ๐ž๐ง ๐ญ๐จ ๐Œ๐’๐“๐จ๐ซ๐จ๐ง๐ญ๐จ2026 ๐ƒ๐š๐ฒ ๐“๐ก๐ซ๐ž๐ž ๐ง๐จ๐ฐ โ€“ ๐š๐ง๐ ๐œ๐š๐ญ๐œ๐ก ๐ฎ๐ฉ ๐จ๐ง ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐ŸŸข ๐’๐ฉ๐จ๐ญ๐ข๐Ÿ๐ฒ: bit.ly/4sFGWt3 ๐ŸŽ ๐€๐ฉ๐ฉ๐ฅ๐ž: apple.co/4ibfyxX ๐Ÿ–ฅ๏ธ ๐–๐ž๐›๐ฌ๐ข๐ญ๐ž: bit.ly/4siotCl Featuring Jaume Sastre-Garriga, ECTRIMS Executive Committee and CEMCAT (Centre d'Esclerosi Mรบltiple de Catalunya), Vall d'Hebron Barcelona Hospital Campus @cemcat_em, @vallhebron, @ECTRIMS, @ACTRIMS, @MTCC_Events, @SeeTorontoNow #ECTRIMS #MSToronto2026 #ECTRIMSPodcast #MultipleSclerosis #MSResearch #Neurology
1
8
467
โฐ LIVE TODAY! Join us at Patient Community Day today, 23 Oct from 15:00-18:00 EDT, where MS experts simplify the latest updates in MS, NMOSD and MOGAD research. Hear from experts as they share the latest research and what it means for your care and treatment. ๐Ÿ“… 23 October 2026 ๐Ÿ•’ 15:00โ€“18:00 EDT ๐ŸŒ Online + Toronto, Canada ๐ŸŒ Live translations available in 50+ languages โžก๏ธ ๐’๐ข๐ ๐ง ๐ฎ๐ฉ: bit.ly/44elQGb Patient Community Day is an opportunity to learn about the latest research advancements directly impacting your ongoing care and treatment options. If you canโ€™t join live โ€“ you can still register to get access the sessions once on-demand. #ECTRIMS4me #PatientCommunityDay #MS #NMOSD #MOGAD
9
466
#MSToronto2026 A very warm welcome to the final day of the 10th Joint ACTRIMS-ECTRIMS Meeting. Start your planning! ๐‚๐ก๐ž๐œ๐ค ๐จ๐ฎ๐ญ ๐ญ๐ก๐ž ๐จ๐ง๐ฅ๐ข๐ง๐ž ๐ฉ๐ซ๐จ๐ ๐ซ๐š๐ฆ๐ฆ๐ž โžก๏ธ bit.ly/4yiNJd5 @ECTRIMS, @ACTRIMS, @MTCC_Events, @SeeTorontoNow #MSToronto2026 #MSResearch #MultipleSclerosis #Neurology
1
13
543
๐ŸŽ™๏ธ From Day Two at #MSToronto2026, Tim Coetzee of @mssociety and Pam Valentine of @MSCanOfficial join us to talk research, collaboration โ€“ and turning scientific progress into real-world impact. ๐ŸŽง ๐‹๐ข๐ฌ๐ญ๐ž๐ง ๐ง๐จ๐ฐ: ๐ŸŸข ๐’๐ฉ๐จ๐ญ๐ข๐Ÿ๐ฒ: open.spotify.com/episode/04Rโ€ฆ ๐ŸŽ ๐€๐ฉ๐ฉ๐ฅ๐ž: podcasts.apple.com/us/podcasโ€ฆ ๐Ÿ–ฅ๏ธ ๐–๐ž๐›๐ฌ๐ข๐ญ๐ž: ectrims.eu/podcast/mstorontoโ€ฆ #ECTRIMSPodcast #MSResearch
2
10
682
๐ƒ๐š๐ฒ ๐Ž๐ง๐ž ๐š๐ญ #๐Œ๐’๐“๐จ๐ซ๐จ๐ง๐ญ๐จ2026 โ€“ ๐š๐ง๐ ๐ฐ๐žโ€™๐ซ๐ž ๐ญ๐š๐ค๐ข๐ง๐  ๐ฒ๐จ๐ฎ ๐ข๐ง๐ฌ๐ข๐๐ž ๐จ๐ง๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฆ๐ž๐ž๐ญ๐ข๐ง๐ โ€™๐ฌ ๐ก๐ž๐š๐๐ฅ๐ข๐ง๐ž ๐ฅ๐ž๐œ๐ญ๐ฎ๐ซ๐ž๐ฌ. Our special MSToronto2026 podcast series continues with Daniel Reich โ€“ the MSToronto2026 Lecturer โ€“ as he joins host Brett Drummond to reflect on some of the key takeaways from the first full day in Toronto. Then, we go deeper. What if imaging could help us connect the dots in MS - from disease mechanisms to networks to the person living with MS? Fresh from his lecture, Unifying Multiple Sclerosis: Imaging from Teams to Tissue to Biology, Daniel takes the conversation beyond the stage: โ€ข What can imaging reveal about the biology driving MS? โ€ข How is it changing the way we understand what is happening in the brain? โ€ข And where could the next generation of imaging take MS research? Recorded direct from Toronto, hear Daniel and Brett unpack Day One โ€“ and go beyond the lecture - with one of the leading figures in MS imaging research. ๐ŸŽง ๐‹๐ข๐ฌ๐ญ๐ž๐ง ๐ญ๐จ ๐จ๐ฎ๐ซ ๐ƒ๐š๐ฒ ๐Ž๐ง๐ž ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐ž๐ฉ๐ข๐ฌ๐จ๐๐ž ๐ง๐จ๐ฐ โ€“ ๐š๐ง๐ ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ ๐ญ๐ก๐ž ๐„๐‚๐“๐‘๐ˆ๐Œ๐’ ๐๐จ๐๐œ๐š๐ฌ๐ญ ๐š๐ฌ ๐ฐ๐ž ๐›๐ซ๐ข๐ง๐  ๐ฒ๐จ๐ฎ ๐ง๐ž๐ฐ ๐ž๐ฉ๐ข๐ฌ๐จ๐๐ž๐ฌ ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐จ๐ฎ๐ญ ๐Œ๐’๐“๐จ๐ซ๐จ๐ง๐ญ๐จ2026. ๐ŸŸข ๐’๐ฉ๐จ๐ญ๐ข๐Ÿ๐ฒ: bit.ly/3TV02hQ ๐ŸŽ ๐€๐ฉ๐ฉ๐ฅ๐ž: apple.co/4ib2tEN ๐Ÿ–ฅ๏ธ ๐–๐ž๐›๐ฌ๐ข๐ญ๐ž: bit.ly/4sh9DfB Featuring Daniel Reich, National Institute of Neurological Disorders and Stroke (NINDS), The National Institutes of Health. @ECTRIMS @ACTRIMS #ECTRIMS #ACTRIMS #MSToronto2026 #ECTRIMSPodcast #MultipleSclerosis #MSResearch #Neuroimaging #Neurology
2
14
610
#MSToronto2026 | Welcome to the 10th Joint ACTRIMS-ECTRIMS Meeting, which officially began today! Be sure to download the #MSToronto2026 app and bookmark the sessions that matter most to you: ๐†๐จ๐จ๐ ๐ฅ๐ž ๐๐ฅ๐š๐ฒ โžก๏ธ bit.ly/4jwoKzj ๐€๐ฉ๐ฉ๐ฅ๐ž โžก๏ธ apple.co/4dJmIbA Todayโ€™s programme is packed, with Scientific Sessions on unifying MS diagnosis and biologically driven disease course descriptors, Hot Topics on BTK inhibitors and digital assessments in MS, and a Nursesโ€™ Session on the state and future of MS nursing, to name a few. ๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐ฉ๐ซ๐จ๐ ๐ซ๐š๐ฆ๐ฆ๐ž ๐ก๐ž๐ซ๐ž โžก๏ธ bit.ly/4yiNJd5 @ECTRIMS, @ACTRIMS, @MTCC_Events, @SeeTorontoNow #MSToronto2026 #MSResearch #MultipleSclerosis #Neurology
3
1
29
1,063
๐Ÿค– How can AI support the future of MS research and clinical practice? ๐‡๐š๐ฉ๐ฉ๐ž๐ง๐ข๐ง๐  ๐ง๐จ๐ฐ ๐š๐ญ #MSToronto2026! Educational Session 6, Understanding #AI in MS: Practical Tools for Clinicians and Researchers, explores how clinicians and researchers can better understand, evaluate and apply emerging AI technologies in their work. Stijn Denissen, Co-Chair of the @ECTRIMS AI & Digital Innovation Committee, is co-chairing the session and presenting A Hitchhiker's Guide to AI in MS. Organised by iAIMS, the session also features AI & Digital Innovation Committee member, Meritxell Bach Cuadra, and Tommy Broeders, with presentations covering an interpretation of AI studies and tools, and the potential applications of large language models in MS research and care. From understanding the technology to evaluating its practical relevance, the session offers valuable perspectives on the opportunities and challenges of #AI in #MS. ๐Ÿ”— ๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐ญ๐ก๐ž #๐Œ๐’๐“๐จ๐ซ๐จ๐ง๐ญ๐จ2026 ๐ฌ๐œ๐ข๐ž๐ง๐ญ๐ข๐Ÿ๐ข๐œ ๐ฉ๐ซ๐จ๐ ๐ซ๐š๐ฆ๐ฆ๐ž: mstoronto2026.virtual-meetinโ€ฆ #ECTRIMS #ACTRIMS #MSToronto2026 #MultipleSclerosis #MSResearch
1
3
11
733
#MSToronto2026๐Ÿ Kicks Off with Over 7,000 Participants from 102 Countries! Opening today, the 10th Joint ACTRIMS-ECTRIMS Meeting features 70 scientific sessions, more than 1,850 posters, and leading experts advancing multiple sclerosis research and care. โ€œBringing together researchers and clinicians from around the world creates important opportunities for collaboration,โ€ said Olga Ciccarelli, Scientific Program Committee Vice Chair. โ€œThese connections are essential to translating scientific advances into better care and outcomes for people living with MS.โ€ For today's press with the latest news from Toronto: ectrims.eu/press-release-mstโ€ฆ #MSResearch #ECTRIMS #ACTRIMS #MultipleSclerosis #NMOSD #MOGAD #Science #PressRelease @ACTRIMS
1
5
464
๐ƒ๐ข๐ซ๐ž๐œ๐ญ ๐Ÿ๐ซ๐จ๐ฆ ๐“๐จ๐ซ๐จ๐ง๐ญ๐จ โ€“ ๐ญ๐ก๐ž ๐œ๐จ๐ง๐ฏ๐ž๐ซ๐ฌ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐ก๐š๐ฏ๐ž ๐š๐ฅ๐ซ๐ž๐š๐๐ฒ ๐›๐ž๐ ๐ฎ๐ง, ๐š๐ง๐ ๐ฐ๐žโ€™๐ฏ๐ž ๐ ๐จ๐ญ ๐ญ๐ก๐ž๐ฆ ๐จ๐ง ๐ซ๐ž๐œ๐จ๐ซ๐! ๐ŸŽ™๏ธ The @ECTRIMS Podcast is coming to you from #MSToronto2026, with a special series of episodes recorded throughout the Joint Meeting โ€“ bringing you highlights, reactions and conversations with some of the leading voices in MS and neuroimmunology. And weโ€™re starting with ๐๐ซ๐ž-๐ƒ๐š๐ฒ. Ann Yeh joins #ECTRIMSPodcast host @MStranslate Brett Drummond to unpack the discussions and highlights from a day dedicated to specialised topics across MS and related neuroinflammatory diseases. What stood out? What should we be paying attention to? And which conversations are already setting the stage for the days ahead? ๐ŸŽง ๐’๐ญ๐š๐ซ๐ญ ๐ฒ๐จ๐ฎ๐ซ ๐Œ๐’๐“๐จ๐ซ๐จ๐ง๐ญ๐จ2026 ๐ฐ๐ž๐ž๐ค ๐ฐ๐ข๐ญ๐ก ๐ฎ๐ฌ โ€“ ๐ฅ๐ข๐ฌ๐ญ๐ž๐ง ๐ญ๐จ ๐ญ๐ก๐ž ๐Ÿ๐ข๐ซ๐ฌ๐ญ ๐ž๐ฉ๐ข๐ฌ๐จ๐๐ž ๐ข๐ง ๐จ๐ฎ๐ซ ๐ฌ๐ฉ๐ž๐œ๐ข๐š๐ฅ ๐‰๐จ๐ข๐ง๐ญ ๐Œ๐ž๐ž๐ญ๐ข๐ง๐  ๐ฉ๐จ๐๐œ๐š๐ฌ๐ญ ๐ฌ๐ž๐ซ๐ข๐ž๐ฌ ๐ง๐จ๐ฐ. ๐ŸŸข ๐’๐ฉ๐จ๐ญ๐ข๐Ÿ๐ฒ: bit.ly/483O6xt ๐ŸŽ ๐€๐ฉ๐ฉ๐ฅ๐ž: apple.co/4k8Y2Nr ๐Ÿ–ฅ๏ธ ๐–๐ž๐›๐ฌ๐ข๐ญ๐ž: bit.ly/4sosdT6 Featuring Ann Yeh, The Hospital for Sick Children(SickKids) / University of Toronto. @ECTRIMS #ECTRIMSPodcast #MSResearch
1
1
8
574
@ECTRIMS Vice President Olga Ciccarelli co-chairs Pre-Day 4: Clinical Course and Outcomes. The session explores recovery after anti-NMDA receptor encephalitis, clinical course across the lifespan, and de-escalation strategies in MOGAD and NMOSD. ๐‰๐จ๐ข๐ง ๐ฎ๐ฌ ๐จ๐ง๐ฅ๐ข๐ง๐ž ๐จ๐ซ ๐ข๐ง ๐ฉ๐ž๐ซ๐ฌ๐จ๐ง โžก๏ธ mstoronto2026.org/ @ECTRIMS, @ACTRIMS, @MTCC_Events, @SeeTorontoNow #MultipleSclerosis #Neurology #MSResearch
1
1
13
594
#MSToronto2026 Pre-Day is underway! Opening the third edition of Pre-Day, @ECTRIMS President Professor Bruno Stankoff highlighted the rapid progress taking place across the field and the importance of bringing experts together to address emerging scientific and clinical challenges. Today's programme features five sessions exploring: โ€ข Disease Mechanisms โ€ข Diagnostic Challenges โ€ข Prognosis and Outcomes Informed by Imaging and Fluid Biomarkers โ€ข Clinical Course and Outcomes โ€ข Treatment Approaches As our understanding of neuroimmunological diseases advances, so too does the need to explore where these conditions converge, where they differ and what these discoveries mean for diagnosis and treatment. Bringing together perspectives on MS, MOGAD, NMOSD, autoimmune encephalitis and other neuroinflammatory conditions, Pre-Day creates an important opportunity to exchange knowledge, strengthen collaboration and advance our collective understanding of neuroimmunology. ๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐ญ๐ก๐ž ๐ฉ๐ซ๐จ๐ ๐ซ๐š๐ฆ๐ฆ๐ž โžก๏ธ bit.ly/4yiNJd5 @ECTRIMS, @ACTRIMS, @MTCC_Events, @SeeTorontoNow #MSToronto2026 #MultipleSclerosis #Neurology #MSResearch
2
2
16
768
#MSToronto2026 kicks off tomorrow at Metro Toronto Convention Centre! We begin on Tuesday with Pre-Day, featuring a deep dive into MS, NMOSD/MOGAD and autoimmune encephalitis. Then, on Wednesday, the 10th Joint ACTRIMS-ECTRIMS Meeting officially begins. Whether youโ€™re joining us in Toronto or online, this is your opportunity to connect with the global MS community and explore the latest advances in MS research. ๐Ÿ‘‰ ๐‘๐ž๐ ๐ข๐ฌ๐ญ๐ž๐ซ ๐Ÿ๐จ๐ซ ๐ฏ๐ข๐ซ๐ญ๐ฎ๐š๐ฅ ๐ฉ๐š๐ซ๐ญ๐ข๐œ๐ข๐ฉ๐š๐ญ๐ข๐จ๐ง ๐ญ๐จ๐๐š๐ฒ: bit.ly/3TXXFum @ECTRIMS, @ACTRIMS, @MTCC_Events, @SeeTorontoNow #MSToronto2026 #MultipleSclerosis #Neurology #MSResearch
1
5
21
823
Good news: If you canโ€™t attend Patient Community Day on 23 Oct 15:00 EDT (Toronto), replays will be available โ€“ so register anyway and be the first to be notified once they are available! ๐’๐ข๐ ๐ง ๐ฎ๐ฉ โžก๏ธ bit.ly/44elQGb @ECTRIMS #ECTRIMS4me #PatientCommunityDay #MS #NMOSD #MOGAD
1
4
9
539
๐Ÿ“ข Reminder: One week left until Patient Community Day โ€“ which will be LIVE in 50+ languages! Join us for this free event, where experts break down valuable insights in MS, NMOSD & MOGAD research. ๐Ÿ—“๏ธ 23 Oct | 15:00 EDT ๐’๐ข๐ ๐ง ๐ฎ๐ฉ โžก๏ธ bit.ly/44elQGb #ECTRIMS4me #PatientCommunityDay #MS #NMOSD #MOGAD
1
1
7
472
๐Ÿš€ The ECTRIMS-MEDEN Fellowship aims to foster collaboration and research on #NMOSD & #MOGAD across Europe. Engage with leading experts & be part of a multi-centre effort. ๐Ÿ“… ๐€๐ฉ๐ฉ๐ฅ๐ฒ ๐›๐ฒ 1 ๐ƒ๐ž๐œ 2026. ๐‹๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž: bit.ly/3Wetzjt Supported by @AlexionPharma, @TheSumairaFDN #ECTRIMSNextGen #MEDEN #Fellowship
1
1
413
๐Ÿ’ฌ โ€œIncluding patient perspectives in what we do makes for better science, better research and better translation into practice.โ€ According to Sinรฉad M. Hynes, Associate Professor of Occupational Therapy at the University of Galway, meaningful patient involvement isn't just beneficialโ€”it's essential. When people affected by MS help guide research, they can identify what is practical, acceptable and most relevant to daily life. The result is research that is more impactful and more likely to improve care. At Patient Community Day, you'll hear how research and lived experience work together to drive progress in MS, NMOSD and MOGAD. ๐ŸŽ“ Learn from leading researchers and clinicians ๐Ÿ”ฌ Understand the latest scientific advances ๐Ÿง‘โ€๐Ÿคโ€๐Ÿง‘ Explore the role of patient engagement in research ๐ŸŒ Connect with a global community Be part of the conversation on 23 October. ๐Ÿ”— ๐’๐ข๐ ๐ง ๐ฎ๐ฉ ๐ง๐จ๐ฐ: bit.ly/4w5pdvp #PatientCommunityDay #PCD2026 #MSResearch #PatientVoice #MultipleSclerosis #MSCommunity #NMOSD #MOGAD #ECTRIMS
2
3
366
๐ŸŽ™๏ธ The #ECTRIMSPodcast is heading to #MSToronto2026! Weโ€™ll be sharing special episodes throughout the Joint Meeting, featuring leading voices in #MSResearch and care. ๐ŸŽง ๐’๐ฎ๐›๐ฌ๐œ๐ซ๐ข๐›๐ž ๐ง๐จ๐ฐ ๐ฌ๐จ ๐ž๐ฏ๐ž๐ซ๐ฒ ๐ง๐ž๐ฐ ๐ž๐ฉ๐ข๐ฌ๐จ๐๐ž ๐ข๐ฌ ๐ซ๐ž๐š๐๐ฒ ๐ฐ๐ก๐ž๐ง ๐ข๐ญ ๐๐ซ๐จ๐ฉ๐ฌ. ๐ŸŸข ๐’๐ฉ๐จ๐ญ๐ข๐Ÿ๐ฒ: bit.ly/4bTWaE8 ๐ŸŽ ๐€๐ฉ๐ฉ๐ฅ๐ž: apple.co/44G3uzz @ECTRIMS #MultipleSclerosis
1
1
317
๐Ÿ”ฌ ๐‚๐š๐ง ๐Œ๐’ ๐ฉ๐ซ๐จ๐ ๐ซ๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐ซ๐ž๐š๐ฅ๐ฅ๐ฒ ๐›๐ž ๐๐ž๐ญ๐ž๐œ๐ญ๐ž๐ ๐ข๐ง ๐ซ๐ž๐š๐ฅ ๐ญ๐ข๐ฆ๐ž? Recognising changes in multiple sclerosis early can make a difference to clinical decision-making. But how can we know whether a change is permanent or temporary? In our latest podcast, two leading MS experts โ€” Professors Helmut Butzkueven and Tjalf Ziemssen โ€” explore both sides of this important debate. From traditional disability assessments to digital technologies and the everyday experiences of people living with MS, the conversation explores how we can better recognise meaningful changes over time. ๐ŸŽง ๐‹๐ข๐ฌ๐ญ๐ž๐ง ๐ง๐จ๐ฐ: ๐ŸŸข ๐’๐ฉ๐จ๐ญ๐ข๐Ÿ๐ฒ: bit.ly/4B59wHT ๐ŸŽ ๐€๐ฉ๐ฉ๐ฅ๐ž ๐๐จ๐๐œ๐š๐ฌ๐ญ๐ฌ: apple.co/4obJlcz ๐ŸŒ ๐„๐‚๐“๐‘๐ˆ๐Œ๐’: bit.ly/4dwQ7pk @ECTRIMS #ECTRIMS #MultipleSclerosis #MSResearch #MSProgression
1
3
6
499
๐Ÿ“ฃ Attention neurologists! #ECTRIMS is offering a unique opportunity to advance your career with the Clinical Training Fellowship Programme. Join leading European MS clinics and research centres to learn cutting-edge techniques in patient management and care. This one-year funded fellowship is open to physicians from all over the world, but training must be completed in Europe. ๐Ÿ—“๏ธ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐๐ž๐š๐๐ฅ๐ข๐ง๐ž: 1 ๐ƒ๐ž๐œ๐ž๐ฆ๐›๐ž๐ซ 2026 ๐Ÿ”— ๐€๐ฉ๐ฉ๐ฅ๐ฒ ๐ก๐ž๐ซ๐ž: bit.ly/3YPJWWI Don't miss this chance to enhance your expertise and make a significant impact in MS care. #ECTRIMSFellowships #ECTRIMSNextGen #ApplyNow #MSResearch #HealthcareProfessionals #Neurology #AdvanceYourCareer #ClinicalTraining #MSCare #Neurology #MedicalFellowship
2
6
409